Literature DB >> 21272327

Isolated sixth cranial nerve palsy as the presenting symptom of a rapidly expanding ACTH positive pituitary adenoma: a case report.

Norman Saffra1, Elizabeth Kaplow, Irina Mikolaenko, Alice Kim, Benjamin Rubin, Jafar Jafar.   

Abstract

BACKGROUND: Pituitary adenoma may present with neuro-ophthalmic manifestations and, typically, rapid tumor expansion is the result of apoplexy. Herein, we present the first case of an isolated sixth cranial nerve palsy as initial feature of a rapidly expanding ACTH positive silent tumor without apoplexy. CASE
PRESENTATION: A 44 year old female with a history of sarcoidosis presented with an isolated sixth cranial nerve palsy as the initial clinical feature of a rapidly expanding ACTH positive silent pituitary adenoma. The patient underwent emergent transsphenoidal hypophysectomy for this rapidly progressive tumor and subsequently regained complete vision and ocular motility. Despite tumor extension into the cavernous sinus, the other cranial nerves were spared during the initial presentation.
CONCLUSIONS: This case illustrates the need to consider a rapidly growing pituitary tumor as a possibility when presented with a rapidly progressive ophthalmoplegia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272327      PMCID: PMC3041999          DOI: 10.1186/1471-2415-11-4

Source DB:  PubMed          Journal:  BMC Ophthalmol        ISSN: 1471-2415            Impact factor:   2.209


  20 in total

1.  Cavernous sinus syndrome: clinical features and differential diagnosis with MR imaging.

Authors:  Jeong Hyun Lee; Ho Kyu Lee; Ji Kang Park; Choong Gon Choi; Dae Chul Suh
Journal:  AJR Am J Roentgenol       Date:  2003-08       Impact factor: 3.959

2.  Ocular palsy occurring with pituitary tumors.

Authors:  C M Robert; J A Feigenbaum; E W Stern
Journal:  J Neurosurg       Date:  1973-01       Impact factor: 5.115

3.  Clinically silent corticotroph tumors of the pituitary gland.

Authors:  B W Scheithauer; A J Jaap; E Horvath; K Kovacs; R V Lloyd; F B Meyer; E R Laws; W F Young
Journal:  Neurosurgery       Date:  2000-09       Impact factor: 4.654

4.  Neuro-ophthalmological findings in sarcoidosis.

Authors:  Kjell Heuser; Emilia Kerty
Journal:  Acta Ophthalmol Scand       Date:  2004-12

Review 5.  Non-functioning pituitary adenomas.

Authors:  Yona Greenman; Naftali Stern
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-10       Impact factor: 4.690

6.  Cavernous sinus syndrome. Analysis of 151 cases.

Authors:  J R Keane
Journal:  Arch Neurol       Date:  1996-10

Review 7.  Sarcoidosis.

Authors:  Nicholas P Jones
Journal:  Curr Opin Ophthalmol       Date:  2002-12       Impact factor: 3.761

8.  Computed tomography versus magnetic resonance imaging for the evaluation of suspected pituitary adenomas.

Authors:  A L Stein; M N Levenick; O A Kletzky
Journal:  Obstet Gynecol       Date:  1989-06       Impact factor: 7.661

9.  Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.

Authors:  K J Bradley; J A H Wass; H E Turner
Journal:  Clin Endocrinol (Oxf)       Date:  2003-01       Impact factor: 3.478

10.  Sudden complete ophthalmoplegia associated with pituitary adenoma.

Authors:  E B Siqueira; J R Lopes; L I Kranzler
Journal:  South Med J       Date:  1983-07       Impact factor: 0.954

View more
  3 in total

Review 1.  The dangers of the "Head Down" position in patients with untreated pituitary macroadenomas: case series and review of literature.

Authors:  Satoshi Kiyofuji; Avital Perry; Christopher S Graffeo; Caterina Giannini; Michael J Link
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

2.  Visual findings as primary manifestations in patients with intracranial tumors.

Authors:  Nazife Sefi-Yurdakul
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

3.  Ocular symptoms as the initial clinical manifestations in patients with extraocular tumors.

Authors:  Jianlong Zheng; Weiqi Chen; Dingguo Huang; Yifan Wang; Dezhi Zheng; Lingling Zhou; Marten E Brelén; Zijing Huang
Journal:  Ann Transl Med       Date:  2021-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.